PD-L1 Expression in High-Risk Non-Muscle-Invasive Bladder Cancer Is Influenced by Intravesical Bacillus Calmette–Guérin (BCG) Therapy

PD-L1 Expression in High-Risk Non-Muscle-Invasive Bladder Cancer Is Influenced by Intravesical Bacillus Calmette–Guérin (BCG) Therapy

In the expanding landscape of immune checkpoint inhibitors (CPI) in high-risk (HR) non-muscle-invasive bladder cancer (NMIBC), the role of programmed death ligand 1 (PD-L1) as prognostic and predictive is increasingly significant. However, data evaluating its variability and susceptibility to Bacill...

Full description

Bibliographic Details
Main Authors: Moritz Maas, Andreas Hilsendecker, Alexandra Pertoll, Viktoria Stühler, Simon Walz, Steffen Rausch, Arnulf Stenzl, Igor Tsaur, Jörg Hennenlotter, Stefan Aufderklamm
Format: Article
Language:English
Published: MDPI AG 2024-03-01
Series:Cancers
Subjects:
bladder cancer
non-muscle-invasive bladder cancer
immunotherapy
BCG
biomarker
Online Access:https://www.mdpi.com/2072-6694/16/7/1356

Internet

https://www.mdpi.com/2072-6694/16/7/1356

Similar Items